According to FutureWise analysis, the European Antimicrobial Susceptibility Testing market in 2025 is US$4.67 billion and is expected to reach US$7.15 billion by 2033, at a CAGR of 5.47%. The European Antimicrobial Susceptibility Testing (AST) market is on the rise, fueled by the urgent challenge of antimicrobial resistance (AMR) that is increasingly affecting healthcare systems. As the demand for swift and precise diagnostic tools skyrockets, this market has become a hotspot for innovation. The advent of automated and molecular-based AST technologies is transforming how we tackle infections, making it easier than ever to pinpoint the right treatment. Government initiatives are stepping up as strong allies in this battle, emphasizing the importance of effective infection control measures. Coupled with rising healthcare expenditures and a growing emphasis on personalized medicine, there are ample opportunities for industry leaders to make a significant impact.At its core, antimicrobial susceptibility testing (AST) is a vital laboratory process that evaluates how well antibiotics and other antimicrobial agents can combat specific pathogens. This testing is crucial, as it informs healthcare professionals in selecting the most effective antimicrobial therapies for bacterial, fungal, and viral infections. By exposing microorganisms to varying concentrations of these agents and determining the minimum inhibitory concentration (MIC) necessary to halt their growth, AST plays a crucial role in guiding effective treatment strategies. In a world facing escalating resistance, the importance of AST cannot be overstated.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Antimicrobial Susceptibility Testing Market trends that shall affect the overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=7885&type=requestsample

By Product

• Automated Laboratory Instruments
• Manual Antimicrobial Susceptibility Testing Products
• Susceptibility Testing Disks
• MIC Strips
• Susceptibility Plates
• Culture and Growth Media
• Consumables

By Method

• Dilution
• Disk Diffusion
• ETEST
• Automated Antimicrobial Susceptibility Testing
• Genotypic Methods

By Type

• Antibacterial Testing
• Antifungal Testing
• Antiparasitic Testing
• Other Susceptibility Testing

By Application

• Clinical Diagnostics
• Drug Discovery and Development
• Epidemiology
• Other Applications

By End User

• Diagnostic Centers and Hospitals
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Research and Academic Institutes Wholesale

• • Retail (in-store)
  • Distributors/ Franchises

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Antimicrobial Susceptibility Testing Market:

• BioMérieux
• BD
• Danaher
• Thermo Fisher
• Bio-Rad Laboratories
• Hi-Media
• Merlin
• Liofilchem
• Accelerate
• Alifax
• Creative Diagnostics
• Merck Group
• Synbiosis
• Bioanalyse
• Zhuhai DL Biotech.

Recent developments by key players in the Antimicrobial Susceptibility Testing Market:

BioMérieux

• VITEK REVEAL has been introduced as an innovative rapid phenotypic antimicrobial susceptibility testing (AST) system, specifically designed for positive blood cultures, providing results in approximately 3 to 6 hours.
• Additionally, the VITEK COMPACT PRO has received FDA clearance, reflecting its status as an updated identification and AST platform with enhanced performance capabilities.

• bioMérieux (France) launched its automated microbiology middleware, MAESTRI,A in early 2023, streamlining lab workflows and enhancing accuracy in AST data management

BD

• Enhanced its Phoenix™ M50 automated ID/AST system with new regulatory approvals. Encountered supply chain issues in blood culture media, affecting some clinical laboratories.
• BD (Becton, Dickinson & Co.) furthered its collaboration with Accelerate Diagnostics (US) by integrating Accelerate’s rapid testing platforms into its global offering, cutting susceptibility result times from days to hours.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=7885&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Antimicrobial Susceptibility Testing Market By Product, By Method, By Type, By Application, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com